Products
 
Jintrolong
Strengths
Features
How to use
Indications
Follitropin
Strengths
Features
Indication
Jintropin AQ
Strengths
Features
Indications
Advantages
User guide to Jintropin AQ
Jintropin for Injection
Strengths
Features
Indications
User guide to Jintropin
Genfulin
Strengths
Features
Indications
How to use
Filgrastim
Strengths
Features
Indications
How to use
Filgrastim PFS
Strengths
Features
Indications
How to use
Octreotide
Strengths
Features
Indications
How to use
PEG products
Linear PEG Derivatives
Branched PEG Derivatives
Multi-Arm PEG Derivatives
PEG Raw Materials
New Products coming soon
Thymosin
 
You are here: Home >> Products >> Jintrolong
 
    

Jintrolong is the first PEG-rhGH launched in the World. It is produced by GenSci using GenSci’s independently developed
GenLei long-acting system, adopting the internationally popular PEG technology. 

Strengths: 
           * 54IU/9.0mg/1.0ml/vial

Features:
           * Administrate once a week 
           * The first PEG-rhGH launched in the World
           * Significantly improved treatment compliance
           * Lower weekly dosing than short-acting rhGH, better efficacy 
           * Same spectrum and similar incidence of adverse reactions compared to short-acting rhGH
           * More optimized treatment plan for children growth hormone deficiency
 
Indications:
           * Pediatric growth retardation due to inadequate secretion of endogenous growth hormone.

How to use:
           * The dose of administration should be subject to physicians. The recommended dose is 0.2mg/kg/dose, once a week by subcutaneous injection (in the upper arm, thigh or abdomen around navel).

 
 

吉ICP备14004136号-1               GeneScience Pharmaceuticals Co., Ltd. (GenSci)  All Rights Reserved